KarenBlochMD

Infectious Disease • Nashville, TN

Associate Professor, Medicine, Vanderbilt University School of Medicine

Join to view full profile

Dr. Bloch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bloch's full profile

Already have an account?

Office
3601 21st Ave S
Nashville, TN 37232
Phone+1 615-322-3000

Fax+1 615-936-0605

Education & Training

University of California (San Francisco)Fellowship, Infectious Disease, 1994 - 1997
Yale-New Haven Medical CenterResidency, Internal Medicine, 1990 - 1993
University of Virginia School of MedicineClass of 1990

Certifications & Licensure

CA State Medical License 1995 - Present
KY State Medical License 2019 - 2025
TN State Medical License 1997 - 2025
CT State Medical License 1993 - 1994

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Publications & Presentations

PubMed

A Clear and Present Danger: Encephalitis due to Infection with Normocellular Cerebrospinal Fluid.
Karen Bloch, Carol Glaser
Clinical Infectious Diseases. 2024-08-03
Executive Summary: State-of-the Art: Acute Encephalitis.
Karen C Bloch, Carol Glaser, David Gaston, Arun Venkatesan
Clinical Infectious Diseases. 2023-09-11
11 citations
State of the Art: Acute Encephalitis.
Karen C Bloch, Carol Glaser, David Gaston, Arun Venkatesan
Clinical Infectious Diseases. 2023-09-11

Press Mentions

Monoclonal Antibody Treatments Scarce After Two Versions Found to Be Ineffective Against OmicronDecember 28th, 2021
State Health Officials from Tennessee Plan to Limit Monoclonal Antibody Treatment to Only Unimmunized IndividualsSeptember 24th, 2021
Monoclonal Antibody Treatment Should Not Replace Vaccinations, Doctors SaySeptember 22nd, 2021
Join now to see all